← Cardiac procedures & devices × liver & masld

TrialThe Journal of clinical endocrinology and metabolism2007

Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

Jose C Florez et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 340 people · 2007

Range includes no effect

No clear effect on liver & MASLD

+24%−1% to +57%

Bigger than 4 in 10 on the map

As reported

HR 1.24, 95% CI 0.99–1.57

One number in the abstract

the abstract, start to end

… than alanine carriers (hazard ratio, 1.24; 95% confidence interval, …

← favours treatmentfavours comparator →
could be chance
Liver & masld
HR 1.240.99–1.57
Cardiac procedures & devicesLiver & MASLD

Cardiac procedures & devices × liver & masldhelps?no deciding trial

unlikelylikely
0.25only evidence
1 / 4

58 papers cite it

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 17213274